Asia Pacific Warts Therapeutics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Common Warts, Genital Warts, Flat Warts, and Others); Treatment (Physical Destruction, Immunomodulation, and Chemical Destruction); End User (Hospitals, Homecare, Specialty Clinics, and Others)
Market Introduction
Warts are skin growth caused by the human papillomavirus (HPV). There are more than 60 types of HPV, some of which tend to cause warts on the skin. Topical treatments could probably resolve the issue of warts in a few weeks with minimal side effects. Topical treatment of may not be effective all the time. Hence, cryotherapy with liquid nitrogen is a suitable option for treatment, where cure rate is 60% to 90% with less than 20% to 10% recurrence rate.
Thus, the new product developments are expected to create a significant demand for warts therapeutics in the coming years, which is further anticipated to drive the warts therapeutics market.
The COVID-19 pandemic has brought unprecedented challenges globally. It has put a major strain on the health systems of many countries around the world and disrupted many services including HPV screening. The COVID-19 pandemic threatens to reverse progress in reducing the burden of HPV in the region. The impact of COVID-19 on North-East Asia is tremendous due to the concentration of economic activities and demographics. While the pandemic has impeded the progress in many of the Sustainable Development Goals (SDGs) and even reversed some of the achievements. Most countries in the subregion have relatively low levels of GDP, further hampering the advancements of the many healthcare policies. In addition, resources are redirected to COVID-19, many state and local public health programs have been unable to sustain pre–COVID-19 levels of activity in the prevention and control of other communicable diseases. Such negative impacts have already been reported regarding HIV, viral hepatitis, STIs, and tuberculosis programs. The decrease in staffing coupled with reduced diagnostic capability resulting in shortages of STD screening and limited ability to perform in-person patient care because of social distancing requirements have negatively impacted the market growth.
Get more information on this report :
Market Overview and Dynamics
The Warts therapeutics market in Asia Pacific is expected to grow from US$ 415.0 million in 2021 to US$ 541.5 million by 2028; it is estimated to grow at a CAGR of 3.9% from 2021 to 2028. Warts are caused by various strains of human papillomaviruses (HPV), and different strains cause warts in different parts of the body. Healthy persons coming in contact with warts can acquire the infection. Moreover, the recurrence rate for genital warts is high. As per the National Center for Biotechnology Information (NCBI), ~30% of total warts cases are expected to regress within the first four months of infection. HPV infections lead to cervical cancer, and cervical cancer is the fourth most common cancer among women. As per the World Health Organization (WHO), ~570,000 new cases of cervical cancer recorded in 2018 with high prevalence in low-income countries. Hence, an increase in the prevalence of HPV infections, leading to a rise in wart cases, and the high recurrence rate of warts are driving the wart therapeutics market growth.
Key Market Segments
In terms of type, the common warts segment accounted for the largest share of the Asia Pacific warts therapeutics market in 2020. In terms of treatment, the physical destruction segment accounted for the largest share of the Asia Pacific warts therapeutics market in 2020. In terms of end user, the hospitals segment accounted for the largest share of the Asia Pacific warts therapeutics market in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the warts therapeutics market in Asia Pacific are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Bausch Health Companies Inc., Euro Vital Pharma GmbH, Cipla Inc., Koninklijke Utermöhlen NV, Scholl's Wellness Company, Teva Pharmaceutical Industries Ltd, GlaxoSmithKline plc., and Novan, Inc.
Reasons to buy report
- To understand the Asia Pacific Warts therapeutics market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for Asia Pacific Warts therapeutics market
- Efficiently plan M&A and partnership deals in Asia Pacific Warts therapeutics market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Asia Pacific Warts therapeutics market
- Obtain market revenue forecast for market by various segments from 2021-2028 in Asia Pacific region.
ASIA PACIFIC WARTS THERAPEUTICS MARKET SEGMENTATION
By Type
- Common Warts
- Genital Warts
- Flat Warts
- Others
By Treatment
- Physical Destruction
- Cryotherapy
- Surgical Removal
- Laser Treatment
- Immunomodulation
- Interferons
- Retinoids
- Zinc
- Chemical Destruction
- Bleomycin
- Cantharidin
- Salicylic Acid
- Others
By End User
- Hospitals
- Homecare
- Specialty Clinics
- Others
By Country
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
Companies Mentioned
- Bausch Health Companies Inc.
- Euro Vital Pharma GmbH
- Cipla Inc.
- Koninklijke Utermöhlen NV
- Scholl's Wellness Company
- Teva Pharmaceutical Industries Ltd
- GlaxoSmithKline plc.
- Novan, Inc
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Warts Therapeutics Market – By Type
1.3.2 Warts Therapeutics Market – By Treatment
1.3.3 Warts Therapeutics Market – By End User
1.3.4 Asia Pacific Warts Therapeutics Market – By Country
2. Asia Pacific Warts Therapeutics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Warts Therapeutics Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Warts Therapeutics Market- Asia Pacific PEST Analysis
4.3 Expert Opinion
5. Asia Pacific Warts Therapeutics Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Human Papillomavirus Infections and Recurrence of Genital Warts
5.1.2 New Product Developments
5.2 Market Restraints
5.2.1 Poor Diagnostics Scenario in Low-Income Countries
5.3 Market Opportunities
5.3.1 Increasing Awareness Regarding STIs
5.4 Future Trends
5.4.1 Emergence of New Technologies
5.5 Impact Analysis
6. Warts Therapeutics Market – Asia Pacific Analysis
6.1 Asia Pacific Warts Therapeutics Market Revenue Forecasts and Analysis
7. Asia Pacific Warts Therapeutics Market Analysis and Forecasts To 2028 – By Type
7.1 Overview
7.2 Warts Therapeutics Market Revenue Share, by Type (2020 and 2028)
7.3 Common Warts
7.3.1 Overview
7.3.2 Common Warts: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Genital Warts
7.4.1 Overview
7.4.2 Genital Warts: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Flat Warts
7.5.1 Overview
7.5.2 Flat Warts: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
8. Asia Pacific Warts Therapeutics Market Analysis and Forecasts To 2028 – By Treatment
8.1 Overview
8.2 Warts Therapeutics Market Revenue Share, by Treatment (2020 and 2028)
8.3 Physical Destruction
8.3.1 Overview
8.3.2 Physical Destruction: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
8.3.2.1 Cryotherapy
8.3.2.2 Cryotherapy: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
8.3.2.3 Surgical Removal
8.3.2.4 Surgical Removal: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
8.3.2.5 Laser Treatment
8.3.2.6 Laser Treatment: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Immunomodulation
8.4.1 Overview
8.4.2 Immunomodulation: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
8.4.2.1 Interferons
8.4.2.2 Interferons: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
8.4.2.3 Retinoids
8.4.2.4 Retinoids: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
8.4.2.5 Zinc
8.4.2.6 Zinc: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Chemical Destruction
8.5.1 Overview
8.5.2 Chemical Destruction: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
8.5.2.1 Bleomycin
8.5.2.2 Bleomycin: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
8.5.3 Cantharidin
8.5.3.1 Overview
8.5.3.2 Cantharidin: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
8.5.3.3 Salicylic Acid
8.5.3.4 Salicylic Acid: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
8.5.3.5 Others
8.5.3.6 Others: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
9. Warts Therapeutics Market Analysis – By End user
9.1 Overview
9.2 Warts Therapeutics Market Revenue Share, by End User (2020 and 2028)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Warts Hospitals Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Homecare
9.4.1 Overview
9.4.2 Homecare: Warts Homecare Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Specialty Clinics
9.5.1 Overview
9.5.2 Specialty Clinics: Warts Specialty Clinics Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
10. Warts Therapeutics Market Revenue and Forecasts to 2028 – Geographical Analysis
10.1 Asia Pacific: Warts Therapeutics Market
10.1.1 Overview
10.1.2 Asia Pacific: Wart Therapeutics Market, by Country, 2021 & 2028 (%)
10.1.2.1 China: Warts Therapeutics Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.1 China: Warts Therapeutics Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.2 China Wart Therapeutics Market, by Type– Revenue and Forecast to 2028 (USD Million)
10.1.2.1.3 China Wart Therapeutics Market, by Treatment– Revenue and Forecast to 2028 (USD Million)
10.1.2.1.3.1 China Wart Therapeutics Market, by Physical Destruction Treatment– Revenue and Forecast to 2028 (USD Million)
10.1.2.1.3.2 China Wart Therapeutics Market, by Immunomodulation Treatment– Revenue and Forecast to 2028 (USD Million)
10.1.2.1.3.3 China Wart Therapeutics Market, by Chemical Destruction Treatment– Revenue and Forecast to 2028 (USD Million)
10.1.2.1.4 China Wart Therapeutics Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.2.2 Japan: Warts Therapeutics Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.1 Japan: Warts Therapeutics Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.2 Japan Wart Therapeutics Market, by Type– Revenue and Forecast to 2028 (Canada Million)
10.1.2.2.3 Japan Wart Therapeutics Market, by Treatment– Revenue and Forecast to 2028 (Canada Million)
10.1.2.2.3.1 Japan Wart Therapeutics Market, by Physical Destruction Treatment– Revenue and Forecast to 2028 (Canada Million)
10.1.2.2.3.2 Japan Wart Therapeutics Market, by Immunomodulation Treatment– Revenue and Forecast to 2028 (Canada Million)
10.1.2.2.3.3 Japan Wart Therapeutics Market, by Chemical Destruction Treatment– Revenue and Forecast to 2028 (Canada Million)
10.1.2.2.4 Japan Wart Therapeutics Market, by End User – Revenue and Forecast to 2028 (Canada Million)
10.1.2.3 India: Warts Therapeutics Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.1 India: Warts Therapeutics Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.2 India Wart Therapeutics Market, by Type– Revenue and Forecast to 2028 (USD Million)
10.1.2.3.3 India Wart Therapeutics Market, by Treatment– Revenue and Forecast to 2028 (USD Million)
10.1.2.3.3.1 India Wart Therapeutics Market, by Physical Destruction Treatment– Revenue and Forecast to 2028 (USD Million)
10.1.2.3.3.2 India Wart Therapeutics Market, by Immunomodulation Treatment– Revenue and Forecast to 2028 (USD Million)
10.1.2.3.3.3 India Wart Therapeutics Market, by Chemical Destruction Treatment– Revenue and Forecast to 2028 (USD Million)
10.1.2.3.4 India Wart Therapeutics Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.2.4 Australia: Warts Therapeutics Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.4.1 Australia: Warts Therapeutics Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.4.2 Australia Wart Therapeutics Market, by Type– Revenue and Forecast to 2028 (USD Million)
10.1.2.4.3 Australia Wart Therapeutics Market, by Treatment– Revenue and Forecast to 2028 (USD Million)
10.1.2.4.3.1 Australia Wart Therapeutics Market, by Physical Destruction Treatment– Revenue and Forecast to 2028 (USD Million)
10.1.2.4.3.2 Australia Wart Therapeutics Market, by Immunomodulation Treatment– Revenue and Forecast to 2028 (USD Million)
10.1.2.4.3.3 Australia Wart Therapeutics Market, by Chemical Destruction Treatment– Revenue and Forecast to 2028 (USD Million)
10.1.2.4.4 Australia Wart Therapeutics Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.2.5 South Korea: Warts Therapeutics Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.5.1 South Korea: Warts Therapeutics Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.5.2 South Korea Wart Therapeutics Market, by Type– Revenue and Forecast to 2028 (USD Million)
10.1.2.5.3 South Korea Wart Therapeutics Market, by Treatment– Revenue and Forecast to 2028 (USD Million)
10.1.2.5.3.1 South Korea Wart Therapeutics Market, by Physical Destruction Treatment– Revenue and Forecast to 2028 (USD Million)
10.1.2.5.3.2 South Korea Wart Therapeutics Market, by Immunomodulation Treatment– Revenue and Forecast to 2028 (USD Million)
10.1.2.5.3.3 South Korea Wart Therapeutics Market, by Chemical Destruction Treatment– Revenue and Forecast to 2028 (USD Million)
10.1.2.5.4 South Korea Wart Therapeutics Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.2.6 Rest of Asia Pacific: Warts Therapeutics Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.6.1 Rest of Asia Pacific: Warts Therapeutics Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.6.2 Rest of Asia Pacific Wart Therapeutics Market, by Type– Revenue and Forecast to 2028 (USD Million)
10.1.2.6.3 Rest of Asia Pacific Wart Therapeutics Market, by Treatment– Revenue and Forecast to 2028 (USD Million)
10.1.2.6.3.1 Rest of Asia Pacific Wart Therapeutics Market, by Physical Destruction Treatment– Revenue and Forecast to 2028 (USD Million)
10.1.2.6.3.2 Rest of Asia Pacific Wart Therapeutics Market, by Immunomodulation Treatment– Revenue and Forecast to 2028 (USD Million)
10.1.2.6.3.3 Rest of Asia Pacific Wart Therapeutics Market, by Chemical Destruction Treatment– Revenue and Forecast to 2028 (USD Million)
10.1.2.6.4 Rest of Asia Pacific Wart Therapeutics Market, by End User – Revenue and Forecast to 2028 (USD Million)
11. Impact Of COVID-19 Pandemic on Asia Pacific Warts Therapeutics Market
11.1 Asia Pacific: Impact Assessment of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. COMPANY PROFILES
13.1 Bausch Health Companies Inc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Euro Vital Pharma GmbH
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Cipla Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Koninklijke Utermöhlen NV
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Scholl's Wellness Company
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 TEVA PHARMACEUTICAL INDUSTRIES LTD
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 GlaxoSmithKline plc.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Novan, Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. China Wart Therapeutics Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 2. China Wart Therapeutics Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 3. China Wart Therapeutics Market, by Physical Destruction Treatment – Revenue and Forecast to 2028 (USD Million)
Table 4. China Wart Therapeutics Market, by Immunomodulation Treatment – Revenue and Forecast to 2028 (USD Million)
Table 5. China Wart Therapeutics Market, by Chemical Destruction Treatment – Revenue and Forecast to 2028 (USD Million)
Table 6. China Wart Therapeutics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 7. Japan Wart Therapeutics Market, by Type – Revenue and Forecast to 2028 (Canada Million)
Table 8. Japan Wart Therapeutics Market, by Treatment – Revenue and Forecast to 2028 (Canada Million)
Table 9. Japan Wart Therapeutics Market, by Physical Destruction Treatment – Revenue and Forecast to 2028 (Canada Million)
Table 10. Japan Wart Therapeutics Market, by Immunomodulation Treatment – Revenue and Forecast to 2028 (Canada Million)
Table 11. Japan Wart Therapeutics Market, by Chemical Destruction Treatment – Revenue and Forecast to 2028 (Canada Million)
Table 12. Japan Wart Therapeutics Market, by End User – Revenue and Forecast to 2028 (Canada Million)
Table 13. India Wart Therapeutics Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 14. India Wart Therapeutics Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 15. India Wart Therapeutics Market, by Physical Destruction Treatment – Revenue and Forecast to 2028 (USD Million)
Table 16. India Wart Therapeutics Market, by Immunomodulation Treatment – Revenue and Forecast to 2028 (USD Million)
Table 17. India Wart Therapeutics Market, by Chemical Destruction Treatment – Revenue and Forecast to 2028 (USD Million)
Table 18. India Wart Therapeutics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 19. Australia Wart Therapeutics Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 20. Australia Wart Therapeutics Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 21. Australia Wart Therapeutics Market, by Physical Destruction Treatment – Revenue and Forecast to 2028 (USD Million)
Table 22. Australia Wart Therapeutics Market, by Immunomodulation Treatment – Revenue and Forecast to 2028 (USD Million)
Table 23. Australia Wart Therapeutics Market, by Chemical Destruction Treatment – Revenue and Forecast to 2028 (USD Million)
Table 24. Australia Wart Therapeutics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 25. South Korea Wart Therapeutics Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 26. South Korea Wart Therapeutics Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 27. South Korea Wart Therapeutics Market, by Physical Destruction Treatment – Revenue and Forecast to 2028 (USD Million)
Table 28. South Korea Wart Therapeutics Market, by Immunomodulation Treatment – Revenue and Forecast to 2028 (USD Million)
Table 29. South Korea Wart Therapeutics Market, by Chemical Destruction Treatment – Revenue and Forecast to 2028 (USD Million)
Table 30. South Korea Wart Therapeutics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 31. Rest of Asia Pacific Wart Therapeutics Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 32. Rest of Asia Pacific Wart Therapeutics Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 33. Rest of Asia Pacific Wart Therapeutics Market, by Physical Destruction Treatment – Revenue and Forecast to 2028 (USD Million)
Table 34. Rest of Asia Pacific Wart Therapeutics Market, by Immunomodulation Treatment – Revenue and Forecast to 2028 (USD Million)
Table 35. Rest of Asia Pacific Wart Therapeutics Market, by Chemical Destruction Treatment – Revenue and Forecast to 2028 (USD Million)
Table 36. Rest of Asia Pacific Wart Therapeutics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 37. Organic Developments Done by Companies
Table 38. Inorganic Developments Done by Companies
Table 39. Glossary of Terms, Warts Therapeutics Market
LIST OF FIGURES
Figure 1. Warts Therapeutics Market Segmentation
Figure 2. Asia Pacific Warts Therapeutics Market Overview
Figure 3. Common Warts Segment Held Largest Share Of Type In Warts Therapeutics Market
Figure 4. India is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Warts Therapeutics Market - Asia Pacific PEST Analysis
Figure 6. Warts Therapeutics Market Impact Analysis of Driver and Restraints
Figure 7. Asia Pacific Warts Therapeutics Market – Revenue Forecasts and Analysis – 2020- 2028
Figure 8. Warts Therapeutics Market Revenue Share, by Type (2020 and 2028)
Figure 9. Common Warts: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 10. Genital Warts: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Flat Warts: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Others: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Warts Therapeutics Market Revenue Share, by Treatment (2020 and 2028)
Figure 14. Physical Destruction: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Cryotherapy: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Surgical Removal: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Laser Treatment: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Immunomodulation: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Interferons: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Retinoids: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Zinc: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Chemical Destruction: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Bleomycin: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Cantharidin: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Salicylic Acid: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Others: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Warts Therapeutics Market Revenue Share, by End User (2020 and 2028)
Figure 28. Hospitals: Warts Hospitals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Homecare: Warts Homecare Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Specialty Clinics: Warts Specialty Clinics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Others: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Asia Pacific: Warts Therapeutics Market, by Key Country – Revenue (2021) (USD Million)
Figure 33. Asia Pacific: Wart Therapeutics Market, by Country, 2021 & 2028 (%)
Figure 34. China Warts Therapeutics Market – Revenue and Forecast to 2028 (USD Million)
Figure 35. Japan Warts Therapeutics Market – Revenue and Forecast to 2028 (USD Million)
Figure 36. India Warts Therapeutics Market – Revenue and Forecast to 2028 (USD Million)
Figure 37. Australia Warts Therapeutics Market – Revenue and Forecast to 2028 (USD Million)
Figure 38. South Korea Warts Therapeutics Market – Revenue and Forecast to 2028 (USD Million)
Figure 39. Rest of Asia Pacific Warts Therapeutics Market – Revenue and Forecast to 2028 (USD Million)
Figure 40. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 41. Growth Strategies Done by the Companies in the Market, (%)
- Bausch Health Companies Inc.
- Euro Vital Pharma GmbH
- Cipla Inc.
- Koninklijke Utermöhlen NV
- Scholl's Wellness Company
- Teva Pharmaceutical Industries Ltd
- GlaxoSmithKline plc.
- Novan, Inc.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific warts therapeutics market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific warts therapeutics market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the warts therapeutics market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution